HEARD, alongside numerous other organisations, would like to draw your attention to the release of a policy brief on the cost-effectiveness of the new HPV vaccination strategy to combat cervical cancer. The policy brief is a critical resource for strengthening South Africa’s fight against cervical cancer.

Link to the policy brief: HPV nonavalent vaccination PolicyBrief FINAL